Jeffrey S. Shaver
Plus aucun poste en cours
Profil
Jeffrey S.
Shaver held several Vice President positions in different pharmaceutical companies such as Dr. Reddy's Laboratories Ltd., Ceptaris Therapeutics, Inc., Ception Therapeutics, Inc., and GSK Plc.
He also worked as a Principal in Smithkline Beecham Pharmaceuticals (India) Ltd.
and the US Air Force.
Shaver earned a doctorate degree from the Massachusetts Institute of Technology, a graduate degree from Purdue University, and an undergraduate degree from the United States Air Force Academy.
Anciens postes connus de Jeffrey S. Shaver
| Sociétés | Poste | Fin |
|---|---|---|
Ceptaris Therapeutics, Inc.
 Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Corporate Officer/Principal | - |
| US Air Force | Corporate Officer/Principal | - |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
| DR. REDDY'S LABORATORIES LIMITED | Corporate Officer/Principal | - |
Formation de Jeffrey S. Shaver
| Purdue University | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| United States Air Force Academy | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Ception Therapeutics, Inc.
 Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Health Technology |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Health Technology |
| US Air Force | Government |
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |
